iifl-logo-icon 1

Shukra Pharmaceuticals Ltd Share Price

91.25
(-1.99%)
Jul 12, 2024|03:45:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open91.25
  • Day's High91.25
  • 52 Wk High129.9
  • Prev. Close93.1
  • Day's Low91.25
  • 52 Wk Low20.43
  • Turnover (lac)17.79
  • P/E22.01
  • Face Value10
  • Book Value13.16
  • EPS4.23
  • Mkt. Cap (Cr.)399.56
  • Div. Yield0.27
No Records Found

Shukra Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

91.25

Prev. Close

93.1

Turnover(Lac.)

17.79

Day's High

91.25

Day's Low

91.25

52 Week's High

129.9

52 Week's Low

20.43

Book Value

13.16

Face Value

10

Mkt Cap (₹ Cr.)

399.56

P/E

22.01

EPS

4.23

Divi. Yield

0.27

Shukra Pharmaceuticals Ltd Corporate Action

16 Aug 2023

12:00 AM

AGM

Announcement Date: 16 Aug, 2023

arrow

10 Jul 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

17 Aug 2023

12:00 AM

BookCloser

arrow

8 Apr 2024

12:00 AM

Bonus

arrow

29 May 2023

12:00 AM

Dividend

Dividend Amount: 0.5

arrow

Shukra Pharmaceuticals Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Shukra Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

13 Jul, 2024|10:59 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 50.95%

Foreign: 0.00%

Indian: 50.95%

Non-Promoter- 0.11%

Institutions: 0.11%

Non-Institutions: 48.92%

Custodian: 0.00%

Share Price

Shukra Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

3.91

1.57

1.57

1.57

Preference Capital

0

0

0

0

Reserves

21.38

14.78

14.03

13.85

Net Worth

25.29

16.35

15.6

15.42

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2020Mar-2019Mar-2018Mar-2017

Revenue

11.84

5.65

5.34

5.13

yoy growth (%)

109.3

5.9

4.02

6.46

Raw materials

-3

-0.99

-0.95

-1.04

As % of sales

25.33

17.5

17.79

20.29

Employee costs

-4.4

-1.96

-1.27

-1.09

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2020Mar-2019Mar-2018Mar-2017

Profit before tax

0.06

0.72

0.94

1.05

Depreciation

-1.47

-0.96

-0.73

-0.46

Tax paid

-0.13

-0.26

-0.42

-0.55

Working capital

0.39

1.47

0.26

0.19

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2020Mar-2019Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

109.3

5.9

4.02

6.46

Op profit growth

-6.61

2.11

10.28

24.06

EBIT growth

-90.08

-26.76

-6.95

15.17

Net profit growth

-92.29

-12.12

4.55

321.93

View Ratios

No Record found

Shukra Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,583.25

124.473,79,874.71867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,581.35

77.171,21,620.455310.652,259507.93

Cipla Ltd

CIPLA

1,505.8

32.731,21,596.061,038.40.563,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,164.3

33.971,17,155.821,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,595.8

25.681,10,037.531,034.80.615,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Shukra Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Dakshesh Shah

Executive Director

Payal Mehta

Independent Director

Bhoomiben Patel

Independent Director

Sarjeevan Singh

Independent Director

Sonal Deepalbhai Gandhi

Executive Director

Sanskruti Patel

Executive Director

Dhruvin Shah

Independent Director

Pinki Nirmal Sagar

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Shukra Pharmaceuticals Ltd (Formerly known Relish Pharmaceuticals Limited) was established in March 1993 and later on the name of Company got changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on 22 September, 2016. The Company is presently engaged in the business of manufacturing of pharmaceuticals Products and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc.The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals com
Read More

Company FAQs

What is the Shukra Pharmaceuticals Ltd share price today?

Down Arrow

The Shukra Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹91.25 today.

What is the Market Cap of Shukra Pharmaceuticals Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Shukra Pharmaceuticals Ltd is ₹399.56 Cr. as of 12 Jul ‘24

What is the PE and PB ratio of Shukra Pharmaceuticals Ltd?

Down Arrow

The PE and PB ratios of Shukra Pharmaceuticals Ltd is 22.01 and 7.07 as of 12 Jul ‘24

What is the 52 Week High and Low of Shukra Pharmaceuticals Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Shukra Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Shukra Pharmaceuticals Ltd is ₹20.43 and ₹129.9 as of 12 Jul ‘24

What is the CAGR of Shukra Pharmaceuticals Ltd?

Down Arrow

Shukra Pharmaceuticals Ltd's CAGR for 5 Years at 104.55%, 3 Years at 206.61%, 1 Year at 112.17%, 6 Month at 162.70%, 3 Month at 14.23% and 1 Month at -7.41%.

What is the shareholding pattern of Shukra Pharmaceuticals Ltd?

Down Arrow

The shareholding pattern of Shukra Pharmaceuticals Ltd is as follows:
Promoters - 50.96 %
Institutions - 0.11 %
Public - 48.93 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.